Popular on eTradeWire


Similar on eTradeWire

Restech Announces French Distribution Agreement with Larylab® Technologies

eTradeWire News/10582275
Larylab—Restech's new French Distributor
The Larylab team combines clinical excellence, practical experience in a clinical setting, and technical expertise with a history of commercial success in bringing global products to the French marketplace.

HOUSTON - eTradeWire -- The Larylab team combines clinical excellence, practical experience in a clinical setting, and technical expertise with a history of commercial success in bringing global products to the French marketplace.

Maya Hallay-Dufour, Vocologist, Founder and Principal of Larylab commented "LPR is the subject of frequent discussions during scientific meetings in France. ENTs, laryngologists, and phoniatricians are limited by available reflux exams and dependent upon gastroenterologists' diagnosis, where, in several cases they do not find an objective explanation for the symptoms. French KOL practitioners all encouraged the introduction of Restech in France, as a long-awaited solution for the best care of their patients with an objective evaluation of LPR."

Restech's Dx-pH System employs proprietary sensor technology which measures aerosolized as well as liquid pH levels, providing up to 48 hours of continuous assessment of reflux exposure propagating symptoms. Using detailed data from the report, clinicians can more precisely treat reflux disorders.

More on eTradeWire News
Thomas Ball, VP Clinical Affairs said, "As LPR and reflux discussions are increasing in France, it is a great honor to help physicians and patients with another diagnostic pathway. Maya gained clinical knowledge of our pH test while working in Luxembourg and Belgium, where her expertise was key to expanding patient diagnosis into new practices."

Debra Krahel, CEO of Restech states "Larylab is an ideal partner for us. Maya's impressive clinical background is critical to educating and implementing this technology into clinical practice. We are excited to put our technology in the hands of premier physicians and clinicians in France."

About Restech

Restech, formed in 2003 is based in Houston, Texas. We believe there is a better way to manage reflux. We are on a mission to find a new approach reflux, ensuring we understand the ins and outs of the disease state. We are passionate about bringing simple, effective solutions across the reflux diagnostic and therapeutic continuum to patients and clinicians around the world.

About LaryLab

Larylab was formed in 2017 and based in Bonneuil-Matours, Nouvelle Aquitaine, France. It all started by creating a specialized training organization in laryngology and vocology that delivers high-quality training sessions all around the year in France. In 2020, Larylab developed a new branch to provide effective devices to support laryngology and vocology practitioners. Our values are to provide high quality devices with scientific evidence of efficacy and security that also responds to ethical care and ecological challenges. Larylab aims to contribute to the well-being and health of patients while reducing public health costs. For this, our range of medical devices is selected meticulously. We are in exclusive partnership with our manufacturers that meet our values, as for their innovative production, extended technical expertise and commitment, in particular in scientific evidence, in guarantee applied on their devices and in technical training support.

More on eTradeWire News
Contact:

Larylab® Technologies
Maya Hallay-Dufour
www.larylab.fr

Contact
Thomas Ball, VP Clinical Affairs
***@restech.com


Source: Respiratory Technology Corporation
stats
Filed Under: Medical, Health, Biotech

Show All News | Report Violation

0 Comments

Latest on eTradeWire News